Susquehanna International Group’s Morphic Holding, Inc. Common Stock MORF Stock Holding History

Susquehanna International Group’s Portfolio MORF Stock Details MORF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-121,200	Closed	-$4.13M	–	13365
2024 Q2	$4.13M	Buy	121,200 +2,300	+2%	+$68.1K	﹤0.01%	3764
2024 Q1	$4.19M	Buy	118,900 +106,000	+822%	+$3.55M	﹤0.01%	3936
2023 Q4	$373K	Sell	12,900 -20,800	-62%	-$495K	﹤0.01%	9356
2023 Q3	$772K	Sell	33,700 -14,900	-31%	-$782K	﹤0.01%	7222
2023 Q2	$2.79M	Sell	48,600 -16,200	-25%	-$846K	﹤0.01%	4495
2023 Q1	$2.44M	Buy	+64,800	New	+$2.39M	﹤0.01%	4738

Other funds holding MORF

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Hoey Investments Coatesville, Pennsylvania $774M AUM 27.34% 1-Year Est. Return

Susquehanna International Group's MORF Position: Q3 2024 in Review

Susquehanna International Group sold out of Morphic Holding, Inc. Common Stock (MORF) in Q3 2024, closing a stake of 85,932 shares — an estimated $2.93M sold.

Susquehanna International Group first reported a position in MORF in Q2 2021 and held it in 11 quarters. The position peaked at $2.93M in Q2 2024. 2 funds tracked by Wall St. Rank hold MORF as of Q3 2024.

Susquehanna International Group reported no remaining Morphic Holding, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Susquehanna International Group sold 85,932 Morphic Holding, Inc. Common Stock shares in Q3 2024, an estimated $2.93M.
Susquehanna International Group first reported a position in Morphic Holding, Inc. Common Stock in Q2 2021 and held it in 11 quarters.
Susquehanna International Group's Morphic Holding, Inc. Common Stock position peaked at $2.93M in Q2 2024.
2 funds tracked by Wall St. Rank held Morphic Holding, Inc. Common Stock as of Q3 2024.

Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.